Iterative Health
Delaware corporation · 10 known investors
Iterative Health operates a network of community-based clinical research sites specializing in gastroenterology, hepatology, obesity, and cardiology trials, partnering with provider networks to connect trial sponsors with high-performing research locations. The company provides AI-powered tools and operational support to accelerate patient enrollment and trial execution in community care settings.
Founders & leadership
JN
Jonathan NgExecutive Officer, Director
PM
Peter MoranDirector
NL
Nan LiDirector
CC
Charles CooneyDirector
Investors · 10
Breyer CapitalAustin · $500K – $10M
G Vision CapitalMountain View
GV (Google Ventures)Mountain View · $250K – $50M
Intrepid Growth PartnersToronto
Micron VenturesSan Jose
Seae VenturesMiami
Tau VenturesPalo Alto · $500K
Time BioVenturesSouthern California
Valor Capital GroupNew York · $100K – $5M
Wavemaker Three-Sixty HealthreportedLos Angeles · $500K – $2M
Reported raises · per SEC filings
Form D private placements▶$140MraisedDec 2021 · 32 investors · BiotechnologyRule 506(b)
▶$140MraisedDec 2021 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles CooneyDirector
- Paul HuberDirector
- Lonne JaffeDirector
- Jonathan NgExecutive Officer, Director
- Peter MoranDirector
- Nan LiDirector
- Offering amount
- $150M
- Amount sold
- $140M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$32.1MraisedAug 2021 · 31 investors · BiotechnologyRule 506(b)
▶$32.1MraisedAug 2021 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan NgExecutive Officer, Director
- Peter MoranDirector
- Nan LiDirector
- Charles CooneyDirector
- Offering amount
- $32.1M
- Amount sold
- $32.1M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.